Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced today that the Phase 2b ACTIVATE study of BIA 28-6156 (pariceract) in patients with Parkinson ...

Investigational Oral Candidate JOTROL™ Addresses a Parkinson’s Disease Market with No Current Disease-modifying Therapies AvailableJupiter, FL, ...

Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced the formation ...

View Minerva Neurosciences Inc NERV stock quote prices, financial information, real-time forecasts, and company news from CNN.

The latest announcement is out from Jupiter Neurosciences, Inc. ( (JUNS) ).

Minerva Neurosciences (NERV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous ...

Minerva Neurosciences (NERV) has been on a downward spiral lately with significant selling pressure. After declining 37.5% over the past four weeks, the stock looks well positioned for a trend ...

View ProMIS Neurosciences Inc. PMN stock quote prices, financial information, real-time forecasts, and company news from CNN.

The Department of Neurosciences offers an interdisciplinary neuroscience training program (INTP). Our program emphasizes cellular, molecular, and systems neuroscience to discover mechanisms that ...

Welcome to the Department of Neurosciences! Together, the Department of Neurosciences at the School of Medicine (SOM), and the Department of Biology in the College of Arts and Sciences (CAS), have ...